Literature DB >> 2961704

Lack of HIV transmission after hepatitis B immunoprophylaxis.

J Genescà, J I Esteban, R Esteban, J M Hernández, J Guardia.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2961704     DOI: 10.1007/bf01647744

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  Effect of Cohn fractionation conditions on infectivity of the AIDS virus.

Authors:  A M Prince; M P Piët; B Horowitz
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

2.  HTLV-III antibody in commercial immunoglobulin.

Authors:  D J Gocke; K Raska; W Pollack; T Schwartzer
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

3.  Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma.

Authors:  M A Wells; A E Wittek; J S Epstein; C Marcus-Sekura; S Daniel; D L Tankersley; M S Preston; G V Quinnan
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

4.  Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-04-11       Impact factor: 17.586

5.  No HTLV-III antibodies after HBV vaccination.

Authors:  L Muylle; P Vranckx; M E Peetermans
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

6.  Safety of immunoglobulin preparation containing anti-HTLV-III.

Authors:  R S Tedder; A Uttley; R Cheingsong-Popov
Journal:  Lancet       Date:  1985-04-06       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.